Hansoh Pharmaceutical Group Co Ltd
3KY
Company Profile
Business description
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.
Contact
287 Xiangke Road
Pudong New District
Shanghai201210
CHNSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
9,313
Stocks News & Analysis
stocks
Finding value in the Aussie mining sector
Is the mining sector overvalued? A new Morningstar report highlights pockets of value that remain.
stocks
Strong start to the year for cheap ASX share
Investors are ignoring a strong long-term outlook.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,793.40 | 29.00 | 0.33% |
| CAC 40 | 7,989.44 | 8.37 | 0.10% |
| DAX 40 | 23,091.87 | 186.98 | -0.80% |
| Dow JONES (US) | 46,245.41 | 493.15 | 1.08% |
| FTSE 100 | 9,531.01 | 3.36 | 0.04% |
| HKSE | 25,578.88 | 358.86 | 1.42% |
| NASDAQ | 22,273.08 | 195.03 | 0.88% |
| Nikkei 225 | 48,625.88 | 1,198.06 | -2.40% |
| NZX 50 Index | 13,499.85 | 80.45 | 0.60% |
| S&P 500 | 6,602.99 | 64.23 | 0.98% |
| S&P/ASX 200 | 8,517.10 | 25.40 | 0.30% |
| SSE Composite Index | 3,821.68 | 13.21 | -0.34% |